Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.75 USD | -0.96% | -1.16% | -16.16% |
May. 10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 316M | Sales 2025 * | 406M | Capitalization | 1.18B |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -1M | EV / Sales 2024 * | 3.43 x |
Net cash position 2024 * | 93.72M | Net cash position 2025 * | 88.72M | EV / Sales 2025 * | 2.68 x |
P/E ratio 2024 * |
-18.6
x | P/E ratio 2025 * |
474
x | Employees | 278 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.31% |
Latest transcript on Mirum Pharmaceuticals, Inc.
1 day | -0.96% | ||
1 week | -1.16% | ||
Current month | -1.43% | ||
1 month | +3.51% | ||
3 months | -14.60% | ||
6 months | -18.48% | ||
Current year | -16.16% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 24.75 | -0.96% | 366,316 |
24-05-15 | 24.99 | +0.77% | 345,099 |
24-05-14 | 24.8 | +0.08% | 377,332 |
24-05-13 | 24.78 | +0.08% | 385,150 |
24-05-10 | 24.76 | -4.14% | 429,935 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.16% | 1.18B | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- MIRM Stock